2019-nCoV Nucleocapsid protein (N-His) (STJP000025) STJP000025-100 上海玉博生物科技有限公司

2019-nCoV Nucleocapsid protein (N-His) (STJP000025)

如果您对该产品感兴趣的话，可以
产品名称：2019-nCoV Nucleocapsid protein (N-His) (STJP000025)
产品型号：STJP000025-100
产品展商：ST john's laboratory
产品文档：无相关文档

简单介绍

2019-nCoV Nucleocapsid protein (N-His) (STJP000025)

产品描述

Host:	E. coli
Note:	STRICTLY FOR FURTHER SCIENTIFIC RESEARCH USE ONLY (RUO). MUST NOT TO BE USED IN DIAGNOSTIC OR THERAPEUTIC APPLICATIONS.
Short Description:	2019-nCoV Nucleocapsid-N-His protein was developed from e. coli and has a target region of N-His. For use in research applications.

Formulation:	Supplied as a 0.22 Mu m filtered solution in 20mM TRIS, 500mM NaCl, 0.1mM EDTA, 10% Glycerol, pH8.0. Contact us for customized product form or formulation.
Immunoreactivity:	Measured by its binding ability in a functional ELISA. Immobilized Recombinant SARS-CoV-2 Nucleocapsid at 2 Mu g/mL (100 Mu L/well) can bind Anti-Nucleocapsid antibody with a linear range of 0.12-1.64 ng/mL.2. Measured by its binding ability in a fun

Immunogen Region:	Met1-Ala419
Immunogen:	Recombinant SARS-CoV-2 (2019-nCoV) Nucleocapsid Protein is produced by E. coli expression system. The target protein is expressed with sequence (Met1-Ala419) of SARS-COV-2 (2019-nCoV) Nucleocapsid (Accession #QHD43423.2) fused with an 6×His tag at th

Background

Recombinant SARS-CoV-2 (2019-nCoV) Nucleocapsid Protein is produced by E. coli expression system. The target protein is expressed with sequence (Met1-Ala419) of SARS-COV-2 (2019-nCoV) Nucleocapsid (Accession #QHD43423.2) fused with an 6×His tag at the N-terminus.

Information sourced from Uniprot.org

12 months for antibodies. 6 months for ELISA Kits. Please see website T&Cs for further guidance

产品留言

标题

联系人

联系电话

内容

验证码

点击换一张

注：1.可以使用快捷键Alt+S或Ctrl+Enter发送信息!
2.如有必要,请您留下您的详细联系方式!

温馨提示：为规避购买风险，建议您在购买前务必确认供应商资质与产品质量。
免责申明：以上内容为注册会员自行发布，若信息的真实性、合法性存在争议，平台将会监督协助处理，欢迎举报

产品目录

产品资料

2019-nCoV Nucleocapsid protein (N-His) (STJP000025)